Familial combined hypolipidemia due to mutations in the ANGPTL3 gene

References

• Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc. Med. 18(1), 6–14 (2008).
   Google Scholar
• Miida T, Hirayama S. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr. Opin. Lipidol. 21(1), 70–75 (2010).
   Google Scholar
• Mattijssen F, Kersten S. Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochim. Biophys. Acta 1821(5), 782–789 (2012).
   Google Scholar
• Bauer RC, Stylianou IM, Rader DJ. Functional validation of new pathways in lipoprotein metabolism identified by human genetics. Curr. Opin. Lipidol. 22(2), 123–128 (2011).
   Google Scholar
• Lichtenstein L, Kersten S. Modulation of plasma TG lipolysis by angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta 1801(4), 415–420 (2010).
   Google Scholar
• Koishi R, Ando Y, Ono M et al. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30(2), 151–157 (2002).
   Google Scholar
• Shimizugawa T, Ono M, Shimamura M et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277(37), 33742–33748 (2002).
   Google Scholar
• Ono M, Shimizugawa T, Shimamura M, Yoshida K et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J. Biol. Chem. 278(43), 41804–41809 (2003).
   Google Scholar
• Köster A, Chao YB, Mosior M et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146(11), 4943–4950 (2005).
   Google Scholar
• Fujimoto K, Koishi R, Shimizugawa T, Ando Y. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp. Anim. 55(1), 27–34 (2006).
   Google Scholar
• Lee EC, Desai U, Gololobov G et al. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J. Biol. Chem. 284(20), 13735–13745 (2009). ▪ Identification of the specific domain of ANGPTL3 involved in the interaction with lipoprotein lipase.
   Google Scholar
• Shan L, Yu XC, Liu Z et al. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J. Biol. Chem. 284(3), 1419–1424 (2009). ▪ Demonstration that ANGPTL3 reduces lipoprotein lipase catalytic activity, but does not alter its self-inactivation rate.
   Google Scholar
• Liu J, Afroza H, Rader DJ, Jin W. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases. J. Biol. Chem. 285(36), 27561–27570 (2010). ▪ Demonstration that, in the presence of cells, ANGPTL3 enhances the cleavage of lipoprotein lipase by pro-protein convertases.
   Google Scholar
• Adeyo O, Goulborne CN, Bensadoun A, Beigneux AP, Fong LG, Young SG. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins. J. Intern. Med. 272(6), 528–540 (2012).
   Google Scholar
• Nilsson SK, Anderson F, Ericsson M et al. Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4. Biochim. Biophys. Acta 1821(10), 1370–1378 (2012).
   Google Scholar
• Sonnenburg WK, Yu D, Lee EC et al. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J. Lipid Res. 50 (12), 2421–2429, (2009).
   Google Scholar
• Shimamura M, Matsuda M, Yasumo H et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler. Thromb. Vasc. Biol. 27(2), 366–372 (2007).
   Google Scholar
• Jin W, Wang X, Millar JS et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab. 6(2), 129–136 (2007).
   Google Scholar
• Jin W, Fuki IV, Seidah NG, Benjannet S, Glick JM, Rader DJ. Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase. J. Biol. Chem. 280(44), 36551–36559 (2005).
   Google Scholar
• Jaye M, Lynch KJ, Krawiec J et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21(4), 424–428 (1999).
   Google Scholar
• Quagliarini F, Wang Y, Kozlitina J et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc. Natl Acad. Sci. USA 109(48), 19751–19756 (2012). ▪▪ Demonstration that ANGPTL3 is activated by ANGPTL8, a novel member of the family of angiopoietin-like proteins.
   Google Scholar
• Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 303(3), e334–e351 (2012).
   Google Scholar
• Zhang R. Lipasin, a novel nutritionallyregulated liver-enriched factor that regulates serum triglyceride levels. Biochem. Biophys. Res. Commun. 424(4), 786–792 (2012).
   Google Scholar
• Tang T, Li L, Tang J et al. A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 28(7), 749–755, (2010).
   Google Scholar
• Hatsuda S, Shoji T, Shinohara K et al. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J. Vasc. Res. 44(1), 61–66 (2007).
   Google Scholar
• Robciuc MR, Tahvanainen E, Jauhiainen M, Ehnholm C. Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J. Lipid Res. 51(4), 824–831 (2010).
   Google Scholar
• Moon HD, Nakajima K, Kamiyama K, Takanashi K, Sakurabayashi I, Nagamine T. Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects. Clin. Chim. Acta 398(1–2), 99–104 (2008).
   Google Scholar
• Kathiresan S, Melander O, Guiducci C et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40(2), 189–197 (2008).
   Google Scholar
• Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010).
   Google Scholar
• Romeo S, Yin W, Kozlitina J, Pennacchio LA et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 119(1), 70–79 (2009).
   Google Scholar
• Pulai JI, Neuman RJ, Groenewegen AW, Wu J, Schonfeld G. Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and nonlinkage to the apoB gene in Caucasian families. Am. J. Med. Genet. 76(1), 79–86 (1998).
   Google Scholar
• Tarugi P, Averna M. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv. Clin. Chem. 54, 81–107 (2011).
   Google Scholar
• Musunuru K, Pirruccello JP, Do R et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363(23), 2220–2227 (2010). ▪ First identification of mutations in the ANGPTL3 gene as the cause of familial combined hypolipidemia.
   Google Scholar
• Pisciotta L, Favari E, Magnolo L et al. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.Circ. Cardiovasc. Genet. 5(1), 42–50 (2012). ▪ Familial combined hypolipidemia is associated with changes in the subtypes and functionality of HDL.
   Google Scholar
• Martín-Campos JM, Roig R, Mayoral C et al. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation. Clin. Chim. Acta 413(5–6), 552–555 (2012).
   Google Scholar
• Minicocci I, Montali A, Robciuc MR et al. Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. J. Clin. Endocrinol. Metab. 97(7), e1266–e1275 (2012). ▪ Identification of a cluster of families with familial combined hypolipidemia sharing the same ANGPTL3 gene mutation.
   Google Scholar
• Noto D, Cefalù AB, Valenti V et al. Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia. Arterioscler. Thromb. Vasc. Biol. 32(3), 805–809 (2012). ▪ Loss-of-function mutations of ANGPTL3 were found in a subset of subjects with the clinical diagnosis of familial hypobetalipoproteinemia associated with low HDL cholesterol levels.
   Google Scholar
• Ando Y, Shimizugawa T, Takeshita S et al. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J. Lipid Res. 44(6), 1216–1223 (2003).
   Google Scholar
• Broedl UC, Maugeais C, Millar JS et al. Endothelial lipase promotes the catabolism of apoB-containing lipoproteins. Circ. Res. 94(12), 1554–1561 (2004).
   Google Scholar
• Maugeais C, Tietge UJ, Broedl UC et al. Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase. Circulation 108(17), 2121–2126 (2003).
   Google Scholar
• Nijstad N, Wiersma H, Gautier T, van der Giet M, Maugeais C, Tietge UJ. 52 Scavenger receptor BI-mediated selective uptake is required for the remodelling of high density lipoprotein by endothelial lipase. J. Biol. Chem. 284(10), 6093–6100 (2009).
   Google Scholar
• Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med. 3(2), e22 (2006).
   Google Scholar
• Khetarpal SA, Edmondson AC, Raghavan A et al. Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol. PLoS Genet. 7(12), e1002393 (2011).
   Google Scholar
• Khera AV, Cuchel M, de la Llera-Moya M et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364(2), 127–135 (2011).
   Google Scholar
• Zhang CC, Kaba M, Ge G et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat. Med. 12(2), 240–245 (2006).
   Google Scholar
• Zheng J, Huynh H, Umikawa M, Silvany R, Zhang CC. Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Blood 117(2), 470–479 (2011).
   Google Scholar